Key Takeaways
- Iran accuses the U.S. of violating a standing ceasefire in the Hormozgan region, warning that it will not hesitate to defend itself as tensions rise in the Strait of Hormuz.
- Eli Lilly (LLY) announces a major strategic pivot with the $4 billion acquisition of three vaccine developers—Curevo, LimmaTech Biologics, and Vaccine Co.
- U.S. credit card stress reaches levels not seen since the 2008 financial crisis, with total balances surging to $1.3 trillion and average interest rates hitting 22%.
- Stellantis (STLA) commits over €1 billion to its Mulhouse plant in France to produce next-generation electric vehicles starting in 2029.
- The U.S. labor market continues to soften, as the Indeed wage tracker shows wage growth slowing to 2.3%, falling behind the current inflation rate of 3.8%.
Geopolitical Friction and the Strait of Hormuz
Tensions between Washington and Tehran reached a new flashpoint on Tuesday as Iran’s Foreign Ministry officially accused the United States of violating the ceasefire in the Hormozgan area. The ministry stated that Iran "will respond and will not hesitate in defending itself," casting doubt on the stability of the indefinite ceasefire originally brokered in April. Despite the rhetoric, Tehran indicated that talks regarding the Strait of Hormuz are ongoing and there is "no plan to close the strait for now," though shipping services may be reviewed under continued U.S. pressure.
In Qatar, top negotiator Mohammad-Bagher Ghalibaf remained for a second day of high-stakes talks aimed at resolving the "last serious sticking point": the unfreezing of Iranian funds. While official confirmation is pending, sources close to the negotiations suggest a resolution may be near through Qatari mediation. Meanwhile, U.S. Interior Secretary Doug Burgum expressed optimism, stating that President Trump is positioned to "come through with a great deal on Iran."
Eli Lilly’s $4 Billion Vaccine Expansion
Pharmaceutical giant Eli Lilly (LLY) made a massive move to diversify its portfolio beyond its dominant obesity and diabetes franchise. The company reached agreements to acquire three vaccine developers—Curevo, LimmaTech Biologics, and Vaccine Co.—in deals with a combined potential value of nearly $4 billion. The acquisitions target high-need areas including shingles, bacterial pathogens (such as S. aureus), and the Epstein-Barr virus.
Under the terms of the deals, Lilly will pay up to $1.5 billion for Curevo and $1.55 billion for Vaccine Co., with the remainder allocated to LimmaTech. This "triple deal" signals Lilly’s intent to become a major player in infectious disease prevention. Analysts note that the company is aggressively deploying cash flow from its GLP-1 revenues to secure long-term growth in the vaccine sector.
U.S. Economic Strain and Labor Softening
The U.S. consumer is showing signs of significant financial distress as credit card debt hits a record $1.3 trillion. With average interest rates touching 22%, delinquency risks have surged to their worst levels since the 2008 Great Recession. This debt mountain is compounded by a 11% plunge in consumer sentiment during May, driven by high gasoline prices and persistent inflation.
Simultaneously, the Indeed wage tracker for April provided a benign reading, showing that wage growth has slowed to 2.3%. This deceleration is in line with a softening labor market where hiring has become "frozen" in many sectors outside of healthcare. Market observers suggest this data makes it difficult to justify more than two "credibility-boosting" rate hikes as the Federal Reserve navigates a high-end neutral interest rate environment.
Corporate and Global Briefs
In the automotive sector, Stellantis (STLA) received a boost from French President Emmanuel Macron, who announced the company will invest more than €1 billion in its Mulhouse plant. The investment is part of a broader strategy to launch a new generation of electric vehicles by 2029. Meanwhile, Xiaomi (XIACY) President confirmed the tech giant will launch its second SUV model later this year, continuing its aggressive expansion into the EV market.
On the diplomatic front, the European Union has summoned Russia’s Charge d'Affairs following recent threats against foreign citizens and diplomats. In the technology space, Hong Kong-based Insilico announced the development of a new longevity AI model in collaboration with an undisclosed U.S. partner, aiming to use artificial intelligence to extend human healthspan.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.